CAD4COVID-CT
ThironaProduct specifications |
Information source:
Vendor
Last updated: Oct. 27, 2020 |
General | |
---|---|
Product name | CAD4COVID-CT |
Company | Thirona |
Subspeciality | Chest |
Modality | CT |
Disease targeted | COVID-19 |
Key-features | COVID-19 analysis, volume quantifications, affected area quantifications, severity scores |
Suggested use | Before: stratifying reading process (non, single, double read), adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps) After: diagnosis verification |
Data characteristics | |
Population | All patients suspected of having COVID-19 |
Input | 3D, Chest CT, multi-slice CT dicom, enhanced CT dicom |
Input format | slice-based dicom files or enhanced dicom file |
Output | segmentation overlay, severity score, affected area, table of quantified values, lobe volumes, emphysema score |
Output format | PDF report and JSON file |
Technology | |
Integration | Integration via AI marketplace or distribution platform, Stand-alone webbased |
Deployment | Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 06-2020 |
Distribution channels | |
Countries present (clinical, non-research use) | 30+ |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |